Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Infertility Drugs Market

Infertility Drugs Market Share

Report ID: GMI5892
Published Date: May 2023
Report Format: PDF

Download Free Sample

Infertility Drugs Market Share

Major market players operating in the infertility drugs market include

Merck KGaA
Ferring B.V.
Abbott
Livzon
Pfizer Inc.
Mankind Pharma
Teva Pharmaceutical Industries Ltd.
IBSA Institut Biochimique SA

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Infertility drugs industry accounted for more than USD 3.5 billion in 2022 and is estimated to reach over USD 6 billion by end of 2032, on account of numerous programs launched by the governments to help people with infertility problems, as well as availability of insurance coverage for therapy.

The parenteral route of administration will generate revenue worth over USD 3.5 billion by end of 2032, as injections and intravenous infusion offer direct & rapid delivery of infertility drugs into the bloodstream, ensuring more efficient & predictable absorption of the drugs, faster onset of action, and improved treatment outcomes.

North America accounted for 43% share in infertility drugs industry in 2022 and will grow at considerable rate through 2032, owing to increasing adoption of a sedentary lifestyle by both women and men leading to infertility issues.

Merck KGaA, Ferring B.V., Abbott, Livzon, Pfizer Inc., Mankind Pharma, Teva Pharmaceutical Industries Ltd., and IBSA Institut Biochimique SA among others.